{"id":20409,"date":"2022-02-04T15:48:20","date_gmt":"2022-02-04T14:48:20","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=20409"},"modified":"2022-02-04T15:48:24","modified_gmt":"2022-02-04T14:48:24","slug":"request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/","title":{"rendered":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence"},"content":{"rendered":"\n<p>Article published on the Bristish Society for Antimicrobial Chemotherapy <a href=\"https:\/\/bsac.org.uk\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\" target=\"_blank\" rel=\"noreferrer noopener\">(BSAC) website<\/a>, On january 27, 2022<\/p>\n\n\n\n<p>The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce a new partnership with Pfizer, focussing on the development of centres of excellence for Antimicrobial Stewardship (AMS) practice, with the goal of reducing inequities in access to AMS programmes and improving patient outcomes.<\/p>\n\n\n\n<p>Part of Pfizer Global Medical Grants (GMG) programme, this Request for Proposal (RFP) aims to solicit programs that have identified a resource limitation within their healthcare organization that impacts the establishment of a holistic and sustainable antimicrobial stewardship (AMS) program. The RFP will support delivery, to successful applicant institutions, of a programme of work to support the development of local AMS programs and will culminate with accreditation of centres and lead to a network of AMS Centres of Excellence across the world that can share learning within their region.<\/p>\n\n\n\n<p>Tracey Guise, BSAC\u2019s Chief Executive Officer, said:<\/p>\n\n\n\n<p><em>\u201cAntimicrobial resistance (AMR) is widely recognized as one of the biggest threats to global health today, with the potential to affect anyone, of any age, in any country. We are therefore excited to announce this ambitious programme, which will not only contribute to containment\/reduction of AMR at local, national, and global level, but also make a significant, sustainable contribution to reducing disparities of access to effective and holistic AMS programmes, improve effective antimicrobial prescribing and deliver improved patient outcomes.\u201d<\/em><\/p>\n\n\n\n<p>Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP,\u00a0<a href=\"https:\/\/cdn.pfizer.com\/pfizercom\/2022-01\/GMG_2022-HOS-G_AMSCentresExcellence%28BSAC%29.pdf?SHkAtnA76XZBL7rz_BC0OnXKEAYK1B..\" target=\"_blank\" rel=\"noreferrer noopener\">full details of which can be found here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Article published on the Bristish Society for Antimicrobial Chemotherapy (BSAC) website, On january 27, 2022 The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce a new partnership with Pfizer, focussing on the development of centres of excellence for Antimicrobial Stewardship (AMS) practice, with the goal of reducing inequities in access to AMS programmes [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":20415,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-04T14:48:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-04T14:48:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"914\" \/>\n\t<meta property=\"og:image:height\" content=\"391\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence\",\"datePublished\":\"2022-02-04T14:48:20+00:00\",\"dateModified\":\"2022-02-04T14:48:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\"},\"wordCount\":278,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\",\"name\":\"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg\",\"datePublished\":\"2022-02-04T14:48:20+00:00\",\"dateModified\":\"2022-02-04T14:48:24+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg\",\"width\":914,\"height\":391,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/","og_locale":"en_GB","og_type":"article","og_title":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-02-04T14:48:20+00:00","article_modified_time":"2022-02-04T14:48:24+00:00","og_image":[{"width":914,"height":391,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence","datePublished":"2022-02-04T14:48:20+00:00","dateModified":"2022-02-04T14:48:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/"},"wordCount":278,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/","name":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg","datePublished":"2022-02-04T14:48:20+00:00","dateModified":"2022-02-04T14:48:24+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/Reseau.jpg","width":914,"height":391,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/request-for-proposals-pfizer-and-bsac-announce-joint-programme-to-establish-antimicrobial-stewardship-ams-centres-of-excellence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Request for Proposals: Pfizer and BSAC announce joint programme to establish Antimicrobial Stewardship (AMS) Centres of Excellence"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-15 02:33:15","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20409"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=20409"}],"version-history":[{"count":5,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20409\/revisions"}],"predecessor-version":[{"id":20423,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20409\/revisions\/20423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/20415"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=20409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=20409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=20409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}